We are pleased to once again offer this widely attended Webinar, which originally aired in September. Eugene Ahn, MD will be on hand to provide a live introduction and audience Q&A following Dr. Abrams' pre-recorded presentation.
As cannabis becomes more widely available for medical purposes increasing numbers of cancer patients are reporting benefit from its use. The published medical literature is thin on evidence. Oncologists report that they often recommend medical cannabis for their patients but describe a lack of knowledge to support their recommendations. An internet lore suggests that cannabis may be useful not only for treating symptoms related to cancer and its treatment but to treating cancer itself. Join us to learn the latest information on integrating cannabis into conventional cancer care.
This webinar is free for SIO members and $20 for non-members. To register, click here.
Donald I. Abrams, MD is an oncologist at Zuckerberg San Francisco General and a Professor of Clinical Medicine at the University of California San Francisco. He has an Integrative Oncology consultation practice at the UCSF Osher Center for Integrative Medicine. Dr. Abrams has conducted extensive research and published on medical cannabis.
Eugene Ahn, MD, is Medical Director of Clinical Research and a hematologist/oncologist with Cancer Treatment Centers of America® (CTCA) in Chicago. Dr. Ahn was the principal investigator on numerous clinical trials focused on improving the treatment of breast cancer and other diseases and he is a frequent author on oncology issues. His blog, "Does Cannabis Cure Cancer?" is available on the SIO website.